Johns Hopkins tissue engineers have used tiny, artificial fiber scaffolds thousands of times smaller than a human hair to help coax stem cells into developing into cartilage, the shock-absorbing lining of elbows and knees that often wears thin from inj…
Author: The Medical News
U.S. News & World Report names Mayo Clinic among 2012 America’s Best Hospitals
Mayo Clinic ranked near the top of the 23rd U.S. News & World Report annual America’s Best Hospital list, earning the No. 3 overall spot on its “Best Hospitals” list. Mayo Clinic in Rochester also was rated best in the nation in three clinical areas –…
U.S. News & World Report names Methodist among 2012 America’s Best Hospitals
The Methodist Hospital ranked among the country’s top hospitals in 13 specialties in U.S. News & World Report’s 2012 America’s “Best Hospitals”issue, and was named the No. 1 hospital in Texas.
Merck to present results from clinical studies on BACE inhibitors at AAIC 2012
Merck, known as MSD outside the United States and Canada, announced today presentations at the upcoming Alzheimer’s Association International Conference (AAIC) being held in Vancouver, British Columbia, Canada on July 14-19, 2012.
ACT treats fourth patient in U.S. clinical trial for Stargardt’s Macular Dystrophy
Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today announced treatment of the fourth patient, the first in the second patient cohort, in its U.S. clinical trial for Stargardt’s Macular Dystrophy (SMD).
Manipulating retinal recipient microenvironment impacts photoreceptor cell transplantation
A research team in the United Kingdom has found that insulin-like growth factor (IGF1) impacts cell transplantation of photoreceptor precursors by manipulating the retinal recipient microenvironment, enabling better migration and integration of the cel…
Prenatal and early childhood exposure to PCE may be associated with long-term visual impairments
Prenatal and early childhood exposure to the chemical solvent tetrachloroethylene (PCE) found in drinking water may be associated with long-term visual impairments, particularly in the area of color discrimination, a new study led by Boston University …
Corneal graft survival better after ALK than PK
Patients treated with anterior lamellar keratoplasty for tectonic indications have better physiologic graft survival outcomes than their counterparts treated with penetrating keratoplasty, despite the former procedure raising the risk for anatomic fail…
Daily IOP changes undermine measurement, medication
Day-to-day variability significantly undermines the precision of intraocular pressure measurement and the estimation of medication effectiveness in glaucoma patients, report researchers.Licensed from Medwire news with permission from Springer Healthcar…
Ampio announces results from Optina trial on DME
Ampio Pharmaceuticals, Inc., a biopharmaceutical company developing innovative proprietary drugs for inflammation, eye disease, kidney disease, CNS disease, metabolic disease and male sexual dysfunction and conducting clinical trials on its three lead …
FDA accepts BLA filing and grants Priority Review to ThromboGenics’ ocriplasmin
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has officially accepted the filing of the Biologics L…
Passive smoking risks children’s distance vision
Passive smoke exposure could lead to long-sightedness in children, show Egyptian study results.Licensed from Medwire news with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse…
Senior citizens report fewer visual impairment problems than their counterparts
Today’s senior citizens are reporting fewer visual impairment problems than their counterparts from a generation ago, according to a new Northwestern Medicine study. Improved techniques for cataract surgery and a reduction in the prevalence of macular …
UI Health first in the Midwest to offer LenSx femtosecond laser for cataract patients
A new laser system for cataract surgery, with accuracy to a few hundred-thousandths of an inch, allows eye surgeons to optimize and customize the incision and ensure the best possible outcome.
Nanoparticles that can slip through mucus barriers shown to protect against herpes infections
Johns Hopkins researchers say they have demonstrated, for the first time in animals, that nanoparticles can slip through mucus to deliver drugs directly to tissue surfaces in need of protection. The researchers used these mucus-penetrating particles (M…
AIO first in the Pittsburgh area to offer laser surgery for cataract removal
Associates in Ophthalmology (AIO), an eye care and surgery practice with seven locations in the Tri-State Area, has become the region’s first medical group to offer bladeless, computer-controlled laser surgery for cataract removal.
Cerebral damage risks vision in children born prematurely
Cerebral damage and retinopathy of prematurity are independently associated with the risk for visual impairment in 4-year-old children who were born prematurely, show Danish study results.Licensed from Medwire news with permission from Springer Healthc…
Cheaper drug to treat wet AMD increases risk of serious eye inflammation
A Queen’s University study of two eye drugs used to treat wet Age-related Macular Degeneration (AMD) has determined the cheaper of the two could lead to eye inflammation, a potentially blinding adverse effect.
Positive results from Salutaris’ episcleral brachytherapy trial on Wet AMD
Positive results from a trial of episcleral brachytherapy to treat Wet Age-related Macular Degeneration (Wet AMD) were presented today at the ARVO Drug and Gene Delivery to the Back of the Eye Conference.
Ophthotech’s Fovista anti-PDGF combination therapy superior to Lucentis for wet AMD
Ophthotech Corporation today announced results from the first clinical trial to show statistically significant superior efficacy over Lucentis (ranibizumab) monotherapy for the treatment of neovascular age-related macular degeneration (wet AMD).